Dr Faye Riley: key facts
- Kind of voice
- Sector leader
- Role
- research communications lead at Diabetes UK
- Quoted on
- Diabetes, Hospital discharge / bed-blocking
- Tracked press citations
- 3
- Most recently quoted
- 30 Sept 2026
- First quoted
- 27 Aug 2026
“Nearly a third of adults with diabetes have some signs of retinopathy, and it is one of the most feared complications of the condition. By identifying the root cause of early damage, and offering a new path for treatment, this research holds immense promise for protecting the sight of people with diabetes worldwide.”
What Dr Faye Riley has said
“Dr Faye Riley, Research Communications Lead at Diabetes UK, explains more about what teplizumab is and how it works”
Research Communications Lead at Diabetes UK · Diabetes · 30 Sept 2026 · Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS ↗
“Weight loss drugs can be effective tools for managing weight and type 2 diabetes risk – but this research reinforces that they are not a quick fix.”
research communications lead at Diabetes UK · Hospital discharge / bed-blocking · 27 Aug 2026 · People who stop taking weight-loss jabs regain weight in under two years, study reveals ↗
Where Dr Faye Riley has been quoted
- Our scientists discover early trigger of diabetic eye diseasediabetes.org.uk · 30 Sept 2026
- Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHSdiabetes.org.uk · 30 Sept 2026
- People who stop taking weight-loss jabs regain weight in under two years, study revealstheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.